Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: The depression-related improvement with vardenafil for erectile response study

American Journal of Psychiatry

Volumn 163, Issue 1, 2006, Pages 79-87

  Rosen, Raymond ^a   Shabsigh, Ridwan ^a   Berber, Mark ^a   Assalian, Pierre ^a   Menza, Mathew ^a   Rodriguez Vela, Luis ^a   Porto, Robert ^a   Bangerter, Keith ^a   Seger, Monica ^a   Montorsi, Francesco ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VARDENAFIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FLUSHING; HAMILTON SCALE; HUMAN; INSOMNIA; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NOSE CONGESTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SIDE EFFECT; SKIN MANIFESTATION;

COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMIDAZOLES; IMPOTENCE; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SULFONES; TREATMENT OUTCOME; TRIAZINES;

EID: 30044451279     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.1.79     Document Type: Article

References (25)

1. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB: Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29:85-96
2. Sadock BJ, Sadock VA (eds): Kaplan and Sadock's Comprehensive Textbook of Psychiatry, 7th ed. Philadelphia, Lippincott Williams & Wilkins, 2000
3. Ferguson JM: The effects of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry 2001; 62(suppl 3):22-34
4. Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB: The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60:458-465
5. Rosen RC, Marin H: Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003; 64(suppl 10):5-10
6. Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC: Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158:1623-1630
7. Nurnberg HG, Gelenberg A, Hargreave TB, Harrison WM, Siegel RL, Smith MD: Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001; 158:1926-1928
8. Nurnberg HG, Hensley PL: Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003; 64(suppl 10):20-25
9. Labbate LA, Croft HA, Oleshansky MA: Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 2003; 64(suppl 10):11-19
10. Nurnberg HG, Hensley PL, Gelenberg AJ, Fava M, Lauriello J, Paine S: Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003; 289:56-64
11. Donatucci C, Eardley I, Buvat J, Gittleman M, Kell P, Segerson T, Homering M, Montorsi F, Vardenafil Study Group: Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. J Sex Med 2004; 1:301-309
12. Porst H, Young JM, Schmidt AC, Buvat J: Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups. Urology 2003; 62:519-523
13. National Institutes of Health Consensus Development Panel on Impotence: NIH consensus conference: impotence. JAMA 1993; 270:83-90
14. Radloff LS: The CES-D Scale: a self-report depression scale for research in the general population. J Applied Psychol Measurement 1977; 1:385-401
15. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH: Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54:346-351
16. Rosenberg M: Society and the Adolescent Self-image. Princeton, NJ, Princeton University Press, 1965
17. Sheehan DV, Lecrubier Y, Sheehan KH, Amorium P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20)22-33
18. Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS: Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52:848-852
19. Althof SE: Quality of life and erectile dysfunction. Urology 2002; 59:803-810
20. Seidman SN: Exploring the relationship between depression and erectile dysfunction in aging men. J Clin Psychiatry 2002; 63(suppl 5):5-12
21. Seidman SN, Roose SP: Sexual dysfunction and depression. Curr Psychiatry Rep 2001; 3:202-208
22. Rosen RC, Seidman SN, Menza MA, Shabsigh R, Roose SP, Tseng LJ, Orazem J, Siegel RL: Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms. Int J Impot Res 2004; 16:334-340
23. Hatzichristou D, Cuzin B, Martin-Morales A, Buvat J, Porst H, Laferriere N, Bandel TJ, Montorsi F, Vardenafil Study Group: Vardenafil improves satisfaction rates, depressive symptomatology, and self-confidence in a broad population of men with erectile dysfunction. J Sex Med 2005; 2:109-115
24. Paykel ES: Remission and residual symptomatology in major depression. Psychopathology 1998; 31:5-14
25. Sadovsky R: Integrating erectile dysfunction treatment into primary care practice. Am J Med 2000; 109(suppl 1):22-28